Annovis Bio (ANVS) Short Interest Ratio & Short Volume → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free ANVS Stock Alerts $6.55 +0.55 (+9.17%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Annovis Bio Short Interest DataCurrent Short Interest1,480,000 sharesPrevious Short Interest1,610,000 sharesChange Vs. Previous Month-8.07%Dollar Volume Sold Short$12.95 millionShort Interest Ratio2.8 Days to CoverLast Record DateMay 15, 2024Outstanding Shares11,171,000 sharesPercentage of Shares Shorted13.25%Today's Trading Volume591,145 sharesAverage Trading Volume444,869 sharesToday's Volume Vs. Average133% Short Selling Annovis Bio ? Sign up to receive the latest short interest report for Annovis Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartANVS Short Interest Over TimeANVS Days to Cover Over TimeANVS Percentage of Float Shorted Over Time Ad Daily Strike Alliance🚀 Tap into this explosive trade opportunity asapI learned about these explosive stocks during my two decades on Wall Street… And used them to help grow my old hedge fund from just a few million to over $700 million dollars*. So it’s safe to say… these bad boys work. What’s the secret behind these special trades? Well, right now, I’m going public with the unique strategy behind these “Calendar Stocks”…Go here to see how you can exploit my next “Calendar Stock”. Annovis Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,480,000 shares $12.95 million -8.1%N/A2.8 $8.75 4/30/20241,610,000 shares $8.89 million +11.0%N/A3.6 $5.52 4/15/20241,450,000 shares $16.11 million -3.3%N/A5.9 $11.11 3/31/20241,500,000 shares $17.85 million +11.1%N/A5.6 $11.90 3/15/20241,350,000 shares $12.30 million -8.2%17.3%4.2 $9.11 2/29/20241,470,000 shares $12.45 million +7.3%19.1%5 $8.47 Get the Latest News and Ratings for ANVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,370,000 shares $15.43 million +4.6%18.0%4.2 $11.26 1/31/20241,310,000 shares $14.45 million +33.7%17.2%4.3 $11.03 1/15/2024980,200 shares $12.59 million +1.7%13.3%3.7 $12.84 12/31/2023963,800 shares $18.02 million +51.6%13.0%4 $18.70 12/15/2023635,600 shares $6.93 million +21.2%8.6%3.5 $10.90 11/30/2023524,500 shares $4.45 million +8.9%7.5%4 $8.49 11/15/2023481,700 shares $2.88 million -7.7%6.9%6.2 $5.97 10/31/2023521,700 shares $3.42 million +23.3%7.2%9.7 $6.56 10/15/2023423,300 shares $3.33 million +25.4%6.7%10.4 $7.86 9/30/2023337,600 shares $3.20 million -8.6%5.3%12.2 $9.49 9/15/2023369,200 shares $3.91 million +6.1%5.8%12.9 $10.60 8/31/2023348,000 shares $4.32 million -5.3%5.5%14.3 $12.40 8/15/2023367,500 shares $4.72 million -2.1%5.8%13.3 $12.83 7/31/2023375,400 shares $5.18 million -9.4%5.9%12.8 $13.79 7/15/2023414,300 shares $5.73 million +1.9%6.5%12.7 $13.82 6/30/2023406,600 shares $5.79 million -5.8%6.4%9.6 $14.25 6/15/2023431,800 shares $6.36 million +11.1%6.8%5.2 $14.74 5/31/2023388,800 shares $5.09 million -1.2%6.4%4.5 $13.10 5/15/2023393,700 shares $5.45 million -20.8%6.5%4.7 $13.85 4/30/2023496,900 shares $7.24 million +6.7%8.2%5.6 $14.57 4/15/2023465,700 shares $7.00 million +30.1%8.4%4.5 $15.03 3/31/2023357,900 shares $5.52 million +39.6%6.4%3.7 $15.41 3/15/2023256,400 shares $4.06 million +2.9%4.6%4.6 $15.84 2/28/2023249,200 shares $4.26 million +6.6%4.5%4.7 $17.11 2/15/2023233,800 shares $4.03 million +22.4%4.2%4.5 $17.22 1/31/2023191,000 shares $3.16 million -1.6%3.4%4.1 $16.52 1/15/2023194,100 shares $2.49 million -2.1%3.4%6.8 $12.81 12/30/2022198,300 shares $2.66 million +21.9%3.5%6.3 $13.43 12/15/2022162,700 shares $1.98 million -4.4%2.9%3.9 $12.16 11/30/2022170,100 shares $2.29 million +7.7%3.0%2.3 $13.44 11/15/2022158,000 shares $2.14 million -11.2%2.8%2.1 $13.55 10/31/2022178,000 shares $2.23 million -9.6%3.2%2.3 $12.55 10/15/2022197,000 shares $2.46 million +13.0%3.5%2.5 $12.50 9/30/2022174,400 shares $2.39 million -22.7%3.1%2 $13.70New trading system called MSFT, NVDA & MSFT (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! 9/15/2022225,700 shares $4.92 million +47.5%4.0%2.1 $21.81 8/31/2022153,000 shares $1.77 million -6.5%2.7%1.9 $11.60 8/15/2022163,700 shares $2.03 million -15.8%2.9%2.2 $12.42 7/31/2022194,300 shares $2.23 million -21.6%3.5%2.6 $11.50 7/15/2022247,900 shares $3.20 million +33.9%4.4%3.2 $12.89 6/30/2022185,100 shares $2.10 million -1.6%3.3%2.5 $11.34 6/15/2022188,100 shares $1.93 million +8.3%3.3%4.7 $10.26 5/31/2022173,700 shares $1.59 million -3.4%3.1%4.3 $9.18 5/15/2022179,800 shares $1.69 million +3.9%3.2%4.4 $9.42 4/30/2022173,100 shares $1.63 million -21.9%3.1%3.8 $9.44 4/15/2022221,500 shares $2.92 million -20.8%3.9%3.8 $13.19 3/31/2022279,600 shares $3.73 million -19.4%5.0%4.2 $13.35 3/15/2022346,800 shares $4.36 million -10.4%6.2%4.1 $12.58 2/28/2022387,100 shares $5.50 million -10.6%6.9%4 $14.20 2/15/2022432,900 shares $6.50 million -6.6%7.8%4.1 $15.01 1/31/2022463,700 shares $7.03 million +5.2%8.3%3.4 $15.17 1/15/2022441,000 shares $6.84 million +11.9%8.1%2.7 $15.52 12/31/2021394,100 shares $6.93 million -8.0%7.2%2.3 $17.58 ANVS Short Interest - Frequently Asked Questions What is Annovis Bio's current short interest? Short interest is the volume of Annovis Bio shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 1,480,000 shares of ANVS short. Learn More on Annovis Bio's current short interest. What is a good short interest ratio for Annovis Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANVS shares currently have a short interest ratio of 3.0. Learn More on Annovis Bio's short interest ratio. Which institutional investors are shorting Annovis Bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Annovis Bio: Ikarian Capital LLC, Affinity Asset Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Annovis Bio's short interest increasing or decreasing? Annovis Bio saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 1,480,000 shares, a decrease of 8.1% from the previous total of 1,610,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Annovis Bio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Annovis Bio: XOMA Co. (2.09%), ADC Therapeutics SA (1.36%), CorMedix Inc. (17.61%), Mersana Therapeutics, Inc. (7.35%), Vanda Pharmaceuticals Inc. (5.08%), Nature's Sunshine Products, Inc. (0.66%), Xeris Biopharma Holdings, Inc. (7.28%), Aquestive Therapeutics, Inc. (6.79%), Revance Therapeutics, Inc. (11.96%), ESSA Pharma Inc. (2.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Annovis Bio stock? Short selling ANVS is an investing strategy that aims to generate trading profit from Annovis Bio as its price is falling. ANVS shares are trading up $0.55 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Annovis Bio? A short squeeze for Annovis Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANVS, which in turn drives the price of the stock up even further. How often is Annovis Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANVS, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: XOMA Short Squeeze ADC Therapeutics Short Squeeze CorMedix Short Squeeze Mersana Therapeutics Short Squeeze Vanda Pharmaceuticals Short Squeeze Nature's Sunshine Products Short Squeeze Xeris Biopharma Short Squeeze Aquestive Therapeutics Short Squeeze Revance Therapeutics Short Squeeze ESSA Pharma Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:ANVS) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTradeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annovis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.